Biggest News Aggregation in the World
📰 Bioscience Inc News

Page 14 - Bioscience Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bioscience Inc. Real-time updates on events, politics, business and more.

Daré Bioscience Announces Achievement of First Commercial Milestone Under License Agreement for ...

SAN DIEGO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the first shipment of XACIATOTM [pronounced zah-she-AH-toe] (clindamycin phosphate)
San Diego United States Camilla White Simona Kormanikova Sabrina Martucci Johnson Bioscience Inc Drug Administration

Short Interest in Yield10 Bioscience, Inc. (NASDAQ:YTEN) Decreases By 26.6%

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) was the target of a significant drop in short interest in September. As of September 30th, there was short interest totalling 131,300 shares, a drop of 26.6% from the September 15th total of 178,900 shares. Based on an average daily trading volume, of 332,800 shares, the days-to-cover […]
United States Jackw Schuler Bioscience Company Profile Wealth Management Millennium Management Bioscience Inc

Short Interest in ZIVO Bioscience, Inc. (NASDAQ:ZIVO) Increases By 43.5%

ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 76,900 shares, an increase of 43.5% from the September 15th total of 53,600 shares. Based on an average daily volume of 14,800 shares, […]
Bioscience Inc Zivo Bioscience Inc Vanguard Group Inc Securities Exchange Commission Get Free Report Free Report

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Major Shareholder Jack W. Schuler Buys 765,000 Shares

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) major shareholder Jack W. Schuler acquired 765,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was bought at an average price of $0.65 per share, with a total value of $497,250.00. Following the completion of the acquisition, the insider now directly […]
United States Jackw Schuler Bioscience Inc Wealth Management Securities Exchange Commission Millennium Management

Critical Survey: YaSheng Group (OTCMKTS:HERB) versus TerrAscend (OTCMKTS:TSNDF)

YaSheng Group (OTCMKTS:HERB – Get Free Report) and TerrAscend (OTCMKTS:TSNDF – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk. Earnings and Valuation This table compares YaSheng […]
United States New Jersey Yasheng Group Bioscience Inc Gansu Yasheng Salt Chemical Industrial Group Ltd Terrascend Corp

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Grupo Aeroportuario (NYSE:ASR), Accolade (NASDAQ:ACCD)

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS.
Toshkent Shahri Pharma Limited Camber Energy Inc Molekule Group Inc Holdings Limited Seastar Medical Holding Corporation

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science